Company intelligence / Profile preview
J & D Pharmaceuticals
New Jersey, United Statesjdpharmaceuticals.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
J & D Pharmaceuticals is developing novel analgesics using proprietary liposomal formulations to improve stability and efficacy in both oral and intravenous treatments. The company has received FDA Rare Pediatric Disease Designation and Orphan Drug Designation for its lead candidates targeting progeria/laminopathies. Its approach combines established small molecule drugs with advanced delivery technologies to address serious conditions like traumatic brain injury, burns, operative pain, and rare genetic disorders.
- Therapeutic areas
- Rare DiseasesNeurology
- Modalities
- Small moleculesLiposomal formulations
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on J & D Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on J & D Pharmaceuticals.